CEO, Cognionics Inc.
President, DTE Energy Ventures
Partner, Latham and Watkins
Senior Partner, Bessemer Venture Partners
Partner, Third Rock Ventures
Co-Founder, Meetup.com
Managing Director, Vulcan Capital
Dean, University of San Diego School of Law
|
|
For cities to truly thrive in this economy, fresh ideas must be cross-pollinated from beyond their borders—and New York offers its share of honey to lure in startups. This international gateway can be the place for companies to break into the... Read more »
I was pretty slow about getting around to reading Thinking, Fast and Slow. The career-capping book by Princeton psychologist Daniel Kahneman, one of the founders of behavioral economics, spent months on all the bestseller lists back in 2011. I finally... Read more »
All eyes in the biotech world will soon turn to the American Society of Clinical Oncology’s annual meeting in Chicago, but for now, the industry keeps humming along. This week’s news was highlighted by partnerships, product launches and big name hirings—and... Read more »
After much clamor about becoming a sanctuary for startups, New York faces the “now what?” stage of its growth as a tech hub.
Plans have been laid down to fill the streets with engineers—in another decade or two. But... Read more »
In a city where people know people who know people, Richard Blakeley sits at the heart of a web that connects New York’s tech community.
That enviable position stems in part from his annual Webutante Ball. While preparing for next Thursday’s... Read more »
OSI Pharmaceuticals became the home-grown beacon of Long Island, NY’s biotech scene behind the lung cancer drug erlotinib (Tarceva), which was so successful that led Japan’s Astellas Pharma to buy the company outright in a $4 billion deal in May 2010.... Read more »
The search for potential investments has led the team at ff Venture Capital in New York into strange waters.
John Frankel, a partner with the firm, says he decided to back UniKey Technologies after hearing about its founder’s appearance last year... Read more »
Yesterday, we ran the first part of a wide-ranging interview with Henri Termeer, the legendary biotech entrepreneur and former CEO of Cambridge, MA-based Genzyme. He spoke about what kinds of startups he likes to get involved in, the trend toward... Read more »
Henri Termeer could have easily faded away into obscurity a couple years ago. The biotech pioneer could have relaxed at his oceanside home in Maine, played a little golf. Or, if he wanted, he could have made loads of money at... Read more »
In the rush to revolutionize taxicabs, the hot new property isn’t a fancy black sedan or a network of hustling cabbies. Instead, digital entrepreneurs are suddenly racing toward the 21st century version of hitchhiking.
So-called “ridesharing” services, which enlist everyday... Read more »
It was a busy week of big promise and big moves for biotechs on the East Coast. One biotech added to a string of partnerships and awaits results from a key mid-stage study for one of its own drugs. Another signed... Read more »
Not every speech is improved by visual aids. Abraham Lincoln made do without PowerPoint at Gettysburg (though wags have tried to reimagine that), and Franklin Roosevelt’s voice on the radio in 1933 calmed a nation rattled by the Great Depression... Read more »
Biotech stars can rise and fall on the key decision of whether or not to “go it alone” and develop their drugs without the help of Big Pharma—it’s a risk that can either make or break a company. But Regado BioSciences,... Read more »
One year after it was announced, the New York Digital Health Accelerator birthed its first clutch of startups on Wednesday at a demo day—including one acquisition deal in the mix.
Pared down from some 250 applicants from across the U.S.... Read more »
Sometimes it feels like all technology roads lead to the New York Tech Meetup. Fresh from Boulder, CO, David Mandell and the team from PivotDesk took the stage at last night’s gathering here to introduce themselves to the New York tech... Read more »
The campaign to attract more startups to New York is reaching across international borders. Last night a coalition of private and city organizations introduced a group of 15 startups from Europe to the New York tech and investor community. The mission... Read more »
The three laws of getting a meeting with a VC: 1) If you don’t know somebody who can provide a referral, don’t even try. 2) Start about four months in advance. 3) Once the meeting is on the books, assume that... Read more »
[Updated with comments from CEO Ofer Shapiro. See below] Imagine being a doctor with patients scattered across the rural reaches of Alaska. Booking face-to-face visits might not be that easy—unless you also happen to be a bush pilot—but having... Read more »
The past 15 months have turned into a partnership symphony for Concert Pharmaceuticals.
On Monday, the Lexington, MA-based company snagged its latest collaborative partner, revealing that it will team with Celgene (NASDAQ: CELG) to use its technology— which adds deuterium... Read more »
President, Rockefeller University
Managing Director, TechStars
Consultant, MJTurner Consulting
President and CEO, Acorda Therapeutics
Chair, Dept. of Biochemistry and Molecular Biophysics, Columbia University
General Partner, Matrix Partners
CEO and Co-Founder of OnSwipe
CEO of PlumAlley
Founder and Managing Partner, IA Ventures
Chair of Dept. of Genetics and Development, Columbia University
San Francisco · 6/3/13
Xconomy offers a number of ways to subscribe for free!
Subscribe Now
